Consolidated Statement Of Cash Flows

Fuso Pharmaceutical Industries,Ltd. - Filing #7732502

Concept As at
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-03-31
As at
2016-09-30
2016-04-01 to
2016-09-30
As at
2016-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
399,000,000 JPY
497,000,000 JPY
Depreciation
923,000,000 JPY
983,000,000 JPY
Interest and dividend income
-49,000,000 JPY
-48,000,000 JPY
Increase (decrease) in provision for retirement benefits
-29,000,000 JPY
1,000,000 JPY
Interest expenses
108,000,000 JPY
111,000,000 JPY
Increase (decrease) in provision for bonuses
19,000,000 JPY
72,000,000 JPY
Decrease (increase) in trade receivables
-276,000,000 JPY
-289,000,000 JPY
Subtotal
1,241,000,000 JPY
1,814,000,000 JPY
Income taxes paid
-364,000,000 JPY
-62,000,000 JPY
Decrease (increase) in inventories
106,000,000 JPY
-218,000,000 JPY
Increase (decrease) in trade payables
-150,000,000 JPY
516,000,000 JPY
Net cash provided by (used in) operating activities
815,000,000 JPY
1,683,000,000 JPY
Other, net
186,000,000 JPY
172,000,000 JPY
Interest and dividends received
49,000,000 JPY
48,000,000 JPY
Loss (gain) on sale of non-current assets
JPY
5,000,000 JPY
Interest paid
-111,000,000 JPY
-117,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-347,000,000 JPY
-1,144,000,000 JPY
Proceeds from sale of property, plant and equipment
JPY
614,000,000 JPY
Net cash provided by (used in) investing activities
-1,160,000,000 JPY
-733,000,000 JPY
Other, net
-83,000,000 JPY
-66,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-425,000,000 JPY
-274,000,000 JPY
Proceeds from long-term borrowings
4,250,000,000 JPY
2,850,000,000 JPY
Net increase (decrease) in short-term borrowings
200,000,000 JPY
JPY
Dividends paid
-356,000,000 JPY
-361,000,000 JPY
Redemption of bonds
-38,000,000 JPY
-38,000,000 JPY
Repayments of long-term borrowings
-1,654,000,000 JPY
-1,780,000,000 JPY
Net cash provided by (used in) financing activities
1,973,000,000 JPY
394,000,000 JPY
Other, net
-1,000,000 JPY
-1,000,000 JPY
Net increase (decrease) in cash and cash equivalents
1,627,000,000 JPY
1,343,000,000 JPY
Cash and cash equivalents
6,579,000,000 JPY
4,951,000,000 JPY
6,349,000,000 JPY
5,006,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.